Teva to get U.S. rights to Andrx products

12/12/2003 | Ha'aretz (Tel Aviv, Israel)

Israel's Teva Pharmaceuticals will get exclusive marketing rights in the U.S. and Canada to Andrx's line of generic oral contraceptive products now awaiting regulatory approval. Financial terms were not disclosed, but analysts said the deal fills holes in Teva's product line and Andrx gets Teva's marketing channels.

View Full Article in:

Ha'aretz (Tel Aviv, Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN